Regina Brown - May 11, 2011 Form 3 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Regina Brown
Stock symbol
LIXT
Transactions as of
May 11, 2011
Transactions value $
$0
Form type
3
Date filed
5/14/2021, 06:10 AM
Next filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LIXT Common Stock 1.3K May 11, 2011 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIXT Options to Purchase Common Stock May 11, 2011 Common Stock 250K $2.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The Reporting Person was granted five-year options to purchase an aggregate of 250,000 shares of the Company's Common Stock vesting 125,000 shares as of May 11,2021 and the remainder vesting on the last day of each subsequent calendar quarter-end until fully vested.